India's Hester Biosciences up on tech deal for avian flu vaccine

Hester Biosciences

28/12/2022 06:48

** Shares of poultry and animal healthcare company Hester
Biosciences Ltd  HEST.NS  up ~2%
    ** Stock reverses course from near session-lows after
company announces deal that will help it make avian flu vaccines
    ** Co signs deal to get technology to develop the low
pathogenic avian influenza (H9N2 strain) inactivated vaccine for
poultry
    ** Plans vaccine launch by end 2023 and exports to African
and Asian countries
    ** Stock has stayed below its 50-day moving average since
mid-Aug, except for four sessions
    ** Stock down ~27% YTD after three consecutive years of
gains
 (Reporting by Dimpal Gulwani in Bengaluru)
 ((dimpal.gulwani@thomsonreuters.com))